This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saribas, Z.
Right arrow Articles by Günalp, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saribas, Z.
Right arrow Articles by Günalp, A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, February 2003, p. 816-818, Vol. 41, No. 2
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.2.816-818.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Rapid Detection of Rifampin Resistance in Mycobacterium tuberculosis Isolates by Heteroduplex Analysis and Determination of Rifamycin Cross-Resistance in Rifampin-Resistant Isolates

Zeynep Saribas,* Tanil Kocagöz, Alpaslan Alp, and Ayfer Günalp

Department of Microbiology and Clinical Microbiology, Hacettepe University Faculty of Medicine, Ankara, Turkey

Received 15 July 2002/ Returned for modification 6 October 2002/ Accepted 22 November 2002

Direct heteroduplex analysis and a universal heteroduplex generator assay were performed to detect rifampin resistance rapidly in Turkish Mycobacterium tuberculosis isolates. Cross-resistance to rifapentine, rifabutin, and rifalazil was investigated. A relationship between specific mutations and resistance patterns, which can guide the choice of an appropriate therapeutic regimen for tuberculosis patients, was identified.

* Corresponding author. Mailing address: Department of Microbiology and Clinical Microbiology, Hacettepe University Faculty of Medicine, 06100 Sihhiye, Ankara, Turkey. Phone: 90-312-305-1560. Fax: 90-312-311-5250. E-mail: zsaribas{at}superonline.com.

Journal of Clinical Microbiology, February 2003, p. 816-818, Vol. 41, No. 2
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.2.816-818.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Soudani, A., Hadjfredj, S., Zribi, M., Masmoudi, A., Messaoud, T., Tiouri, H., Fendri, C. (2007). Characterization of Tunisian Mycobacterium tuberculosis Rifampin-Resistant Clinical Isolates. J. Clin. Microbiol. 45: 3095-3097 [Abstract] [Full Text]  
  • Kocagoz, T., Saribas, Z., Alp, A. (2005). Rapid Determination of Rifampin Resistance in Clinical Isolates of Mycobacterium tuberculosis by Real-Time PCR. J. Clin. Microbiol. 43: 6015-6019 [Abstract] [Full Text]  
  • Kapoor, A., Jones, M., Shafer, R. W., Rhee, S.-Y., Kazanjian, P., Delwart, E. L. (2004). Sequencing-Based Detection of Low-Frequency Human Immunodeficiency Virus Type 1 Drug-Resistant Mutants by an RNA/DNA Heteroduplex Generator-Tracking Assay. J. Virol. 78: 7112-7123 [Abstract] [Full Text]  
  • Sajduda, A., Brzostek, A., Poplawska, M., Augustynowicz-Kopec, E., Zwolska, Z., Niemann, S., Dziadek, J., Hillemann, D. (2004). Molecular Characterization of Rifampin- and Isoniazid-Resistant Mycobacterium tuberculosis Strains Isolated in Poland. J. Clin. Microbiol. 42: 2425-2431 [Abstract] [Full Text]  
  • Chaisson, R. E. (2003). Treatment of Chronic Infections with Rifamycins: Is Resistance Likely To Follow?. Antimicrob. Agents Chemother. 47: 3037-3039 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»